Bristol-Myers Squibb’s PRAVACHOL (pravastatin sodium) granted expanded usage from the FDA

,

In 1994, Bristol-Myers Squibb’s PRAVACHOL (pravastatin sodium) was granted expanded usage from the U.S. Food and Drug Administration (FDA).

Tags:


Source: National Library of Medicine
Credit:

Advertise in our E-history sent to 5,000 plus company decision makers twice per month for only $300 per month. Reserve your space now! E-mail: info@LifeScienceHistory.com.